StreetInsider.com News Articles

Form 8-K GridAI Technologies Corp For: Nov 28

Thu, 04 Dec 2025 17:21:00 -0500

si-local-file:///var/storage/secattach/20251204/25702375.html

Form 8-K GridAI Technologies Corp For: Nov 28

Thu, 04 Dec 2025 17:21:00 -0500

si-local-file:///var/storage/secattach/20251204/25702375.html

Entero Therapeutics to change name to GridAI Technologies

Fri, 28 Nov 2025 08:00:08 -0500

Entero Therapeutics, Inc. (NASDAQ: ENTO) announced it will change its corporate name to GridAI Technologies Corp., effective December 1, 2025, at 12:01 Eastern Time. The company will also change its ticker symbol to "GRDX" and begin trading under the new name on the Nasdaq Capital Market on the same date.

The name change follows Entero's acquisition of 100% of GRID AI Corp, a company that develops AI-driven software and controls platforms for utilities, retail energy providers, and large power users to manage load and distributed energy resources, including battery energy storage systems.

"This marks the beginning of a new chapter for the

Entero Therapeutics, Inc. Announces Corporate Name Change to GridAI Technologies Corp. and New Ticker Symbol "GRDX"

Fri, 28 Nov 2025 08:00:00 -0500

BOCA RATON, FL / ACCESS Newswire / November 28, 2025 / Entero Therapeutics, Inc. (NASDAQ:ENTO) (the "Company") today announced that it will change its name to GridAI Technologies Corp., effective at 12:01 Eastern Time on Monday, December 1, 2025. The name change closely aligns the Company's business following its acquisition of 100% of GRID AI Corp ("GRID AI"), a grid-edge, AI-driven software and controls platform that enables utilities, retail energy providers, and large power users to dynamically manage load and distributed energy resources including battery energy storage systems. In connection with the

Entero Therapeutics, Inc. Announces Corporate Name Change to GridAI Technologies Corp. and New Ticker Symbol "GRDX"

Fri, 28 Nov 2025 08:00:00 -0500

Form 10-Q Entero Therapeutics, For: Sep 30

Wed, 19 Nov 2025 17:14:00 -0500

si-local-file:///var/storage/secattach/20251119/25639202.html

Form 10-Q Entero Therapeutics, For: Sep 30

Wed, 19 Nov 2025 17:14:00 -0500

si-local-file:///var/storage/secattach/20251119/25639202.html

ENTO unit Grid AI signs intent letter with AI data center developer

Wed, 19 Nov 2025 08:45:31 -0500

Entero Therapeutics Inc. (NASDAQ: ENTO) announced that its subsidiary Grid AI has signed a letter of intent with an undisclosed artificial intelligence data center developer to deploy Grid AI's power optimization platform at the customer's first large-scale AI campus in Texas.

The agreement represents Grid AI's first hyperscaler contract and is scheduled to generate approximately $8 million in annual revenue in 2027, scaling to over $50 million in 2029. The Texas campus is expected to begin generating revenue for Grid AI in the third quarter of 2026.

The definitive commercial contract is expected to be executed in early 2026, according to the

ENTO Subsidiary Grid AI Announces Letter of Intent with First Hyperscaler AI Data-Center Customer

Wed, 19 Nov 2025 08:45:00 -0500

BOCA RATON, FLORIDA / ACCESS Newswire / November 19, 2025 / Entero Therapeutics, Inc. (NASDAQ:ENTO) ("Entero" or the "Company") today announced that its subsidiary Grid AI has executed a Letter of Intent (LOI) with a stealth-mode hyperscaler artificial intelligence (AI) data-center developer to deploy Grid AI's advanced power-cluster optimization and orchestration platform at the customer's first large-scale AI campus. The campus-expected to be among the more sophisticated AI-ready digital-infrastructure sites in development-will be located in the ERCOT market in Texas.

The LOI represents Grid AI's first hyperscaler agreement and marks a major milestone

ENTO Subsidiary Grid AI Announces Letter of Intent with First Hyperscaler AI Data-Center Customer

Wed, 19 Nov 2025 08:45:00 -0500

The LOI represents Grid AI's first hyperscaler agreement and marks a major milestone

Form NT 10-Q Entero Therapeutics, For: Sep 30

Mon, 17 Nov 2025 16:01:00 -0500

si-local-file:///var/storage/secattach/20251117/25625014.html

Form NT 10-Q Entero Therapeutics, For: Sep 30

Mon, 17 Nov 2025 16:01:00 -0500

si-local-file:///var/storage/secattach/20251117/25625014.html

Form SCHEDULE 13G Entero Therapeutics, Filed by: RENAISSANCE TECHNOLOGIES LLC

Thu, 13 Nov 2025 14:28:00 -0500

si-local-file:///var/storage/secattach/20251113/25606007.html

Form SCHEDULE 13G Entero Therapeutics, Filed by: RENAISSANCE TECHNOLOGIES LLC

Thu, 13 Nov 2025 14:28:00 -0500

si-local-file:///var/storage/secattach/20251113/25606007.html

Entero Therapeutics plans US leadership team for Grid AI subsidiary

Thu, 13 Nov 2025 08:36:13 -0500

Entero Therapeutics Inc. (NASDAQ: ENTO) announced it is establishing a US-based leadership team for its subsidiary Grid AI as part of an expansion into the American market for AI infrastructure technology.

The company expects to name a US-based chief executive officer and executive chairman for Grid AI in the near term. According to the announcement, the incoming executives have experience in public markets and previously led a global publicly traded company in the demand-response and energy-flexibility sector.

Grid AI develops AI orchestration and energy optimization technology for data centers and enterprise AI deployments. The subsidiary focuses on intelligent control systems and real-time

Entero Therapeutics plans US leadership team for Grid AI subsidiary

Thu, 13 Nov 2025 08:36:13 -0500

Grid AI develops AI orchestration and energy optimization technology for data centers and enterprise AI deployments. The subsidiary focuses on intelligent control systems and real-time

Entero's Grid AI Prepares for Major U.S. Expansion with New Leadership Appointments to Accelerate AI Infrastructure Strategy

Thu, 13 Nov 2025 08:35:00 -0500

Timed with a sharp acceleration in AI-data-center expansion, with more than $60B in new projects announced in the last 90 days.

BOCA RATON, FL / ACCESS Newswire / November 13, 2025 / Entero Therapeutics, Inc. (NASDAQ:ENTO) ("Entero" or the "Company") today announced that its wholly owned subsidiary, Grid AI, is finalizing the establishment of a U.S.-based leadership team composed of highly accomplished executives from the energy, power, and technology sectors. This marks a significant step in Grid AI's expansion into the rapidly growing U.S. market for AI-ready digital infrastructure and orchestration technology.

Entero expects

Entero's Grid AI Prepares for Major U.S. Expansion with New Leadership Appointments to Accelerate AI Infrastructure Strategy

Thu, 13 Nov 2025 08:35:00 -0500

Timed with a sharp acceleration in AI-data-center expansion, with more than $60B in new projects announced in the last 90 days.

Entero expects

Form 8-K Entero Therapeutics, For: Oct 17

Thu, 06 Nov 2025 16:04:00 -0500

si-local-file:///var/storage/secattach/20251106/25570614.html

Form 8-K Entero Therapeutics, For: Oct 17

Thu, 06 Nov 2025 16:04:00 -0500

si-local-file:///var/storage/secattach/20251106/25570614.html

Entero subsidiary Grid AI signs letter of intent to integrate LV Grid team

Thu, 06 Nov 2025 08:45:33 -0500

Entero Therapeutics Inc. (NASDAQ: ENTO) announced it signed a letter of intent to integrate the LV Grid engineering team and intellectual property into its subsidiary Grid AI.

Under the proposed structure, LV Grid's team will join Grid AI to lead development of its AI Data Center Controls division. Václav Moulis, CEO of LV Grid, will become Chief Technology Officer of Grid AI following the integration.

Grid AI plans to deploy an integrated digital-dispatch and campus-optimization engine, starting with an AI data center energy park in Texas. The project is designed to validate economics of behind-the-meter generation and storage for hyperscale operators.

"Grid AI

Entero Subsidiary Grid AI Accelerates Expansion into Hyperscaler AI Data Center Market with Integration of LV Grid

Thu, 06 Nov 2025 08:45:00 -0500

Integration boosts Grid AI's deployment capacity as AI data-center power demand approaches 50 GW, growing by over 165% through 2030ⁱ

BOCA RATON, FL / ACCESS Newswire / November 6, 2025 / Entero Therapeutics, Inc. (NASDAQ:ENTO) ("ENTO" or the "Company"), the parent company of Grid AI, announced today the signing of a Letter of Intent to integrate the LV Grid engineering team and related intellectual property into Grid AI.

The company believes the addition of LV Grid marks a critical step in Grid AI's strategy to capture a leading position in the rapidly expanding AI